PI
-
Surface downmodulation of TIM3 safeguards healthy cells but not acute myeloid leukemia from CAR T-cell therapy
van der Schans, J. J., Vishwasrao, P., Poels, R., Antti, M., Wang, Z., Quik, M., van Arkel, J., Reuvekamp, T., van de Donk, N. W. C. J., Themeli, M., Ossenkoppele, G. J., van de Loosdrecht, A. A., Richards, R. & Mutis, T., 1 Jul 2025, In: HemaSphere. 9, 7, e70155.Research output: Contribution to journal › Article* › Academic › peer-review
-
Applications of machine learning for immunophenotypic measurable residual disease assessment in acute myeloid leukemia
Mocking, T. R., van de Loosdrecht, A. A., Cloos, J. & Bachas, C., 21 May 2025, In: HemaSphere. 9, 5, 8 p., e70138.Research output: Contribution to journal › Review article* › Academic › peer-review
-
Different features of acute myeloid leukemia stem cell quantification in intensively treated patients
Ngai, L. L., Reuvekamp, T., Hanekamp, D., Janssen, F., Marsbergen, L.O.-V., Carbaat-Ham, J., Hofland, M. A. M., Fayed, M. M. H. E., Kelder, A., Snel, A. N., Bachas, C., Tettero, J. M., Breems, D. A., Fischer, T., Gjertsen, B. T., Griškevičius, L., Juliusson, G., Van de Loosdrecht, A. A., Maertens, J. A. & Manz, M. G. & 9 others, , 30 Apr 2025, (E-pub ahead of print) In: Haematologica.Research output: Contribution to journal › Article* › Academic › peer-review
- All publications